About Biocomposites
Biocomposites is a company based in Keele (United Kingdom) founded in 1999 by John Joseph Cooper, John Stephen Bratt, and Russell David Waters. Biocomposites has raised $1.8 million across 2 funding rounds from investors including Novo Holdings and TA Associates. Biocomposites has completed 1 acquisition, including ARTOSS. Biocomposites operates in a competitive market with competitors including MiMedx Group, Ossio, EpiBone, CartiHeal and Theradaptive, among others.
- Headquarter Keele, United Kingdom
- Founders John Joseph Cooper, John Stephen Bratt, Russell David Waters
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocomposites (Uk) Limited
- Date of Incorporation 06 Oct, 1999
- Jurisdiction NEWCASTLE, STAFFS
-
Annual Revenue
$53.36 M (USD)40as on Dec 31, 2016
-
Net Profit
$26.49 M (USD)0as on Dec 31, 2017
-
EBITDA
Not available
-
Total Equity Funding
$1.8 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Novo Holdings
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Biocomposites
Unlock access to complete
Funding Insights of Biocomposites
Biocomposites has successfully raised a total of $1.8M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biocomposites
Biocomposites has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Novo Holdings and TA Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by private equity firm TA.
|
Locked | Locked | Locked |
Investor details for Biocomposites
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocomposites
Biocomposites has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ARTOSS.
Investment portfolio details for Biocomposites
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Orthopedic and dental devices are distributed by ARTOSS.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Biocomposites
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biocomposites
Detailed financials for Biocomposites
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocomposites Comparisons
Peer comparison for Biocomposites
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocomposites
Biocomposites operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Ossio, EpiBone, CartiHeal and Theradaptive, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
Detailed competitors of Biocomposites
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocomposites
Complete news archive for Biocomposites
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocomposites
Biocomposites was founded in 1999 and raised its 1st funding round 18 years after it was founded.
Biocomposites is headquartered in Keele, United Kingdom. It is registered at Keele, England, United Kingdom.
Biocomposites is a funded company, having raised a total of $1.8M across 2 funding rounds to date.
Annual revenue of Biocomposites is $53.36M as on Dec 31, 2016.
Developer of synthetic calcium composite products for bone repair and regeneration. The products include STIMULAN an absorbable calcium sulfate designed to be placed directly at the site of infection in bone and soft tissues. genex ia a synthetic bone graft substitute aimed at supporting natural bone healing, Biosteon is an osteoconductive calcium phosphate composite, AllogranR Bilok used in trauma, spine, and sports injury applications, and NanoBone SBX PuttyQD is a nanostructured hydroxyapatite grafts cleared for interbody spinal fusion.
Biocomposites's top competitors include EpiBone, Theradaptive and MiMedx Group.
Biocomposites has made 1 acquisition, including ARTOSS.
Biocomposites has 2 investors. Key investors include Novo Holdings, and TA Associates.
The valuation of Biocomposites is $35.14M as of Mar 2017.